Search research articles
Contact Us
Filters
Showing results (31-40 of 126) with videos related to
Page
of 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2005
T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization
Katayoun Rezvani, Jason M Brenchley, David A Price, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2007
Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation
Bipin N Savani, Stephan Mielke, Katayoun Rezvani, et al.
Blood
|
November 8, 2008
Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
Katayoun Rezvani, Agnes S M Yong, Abdul Tawab, et al.
Blood
|
November 15, 2014
Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy
Mathias Lutz, Andrea Worschech, Miriam Alb, et al.
Haematologica
|
December 8, 2010
Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies
Katayoun Rezvani, Agnes S M Yong, Stephan Mielke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2005
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel
Anja Henningsson, Sharon Marsh, Walter J Loos, et al.
Cancer Immunology, Immunotherapy : CII
|
December 27, 2011
Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy
Katayoun Rezvani, Agnes S M Yong, Stephan Mielke, et al.
Blood
|
September 20, 2007
A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique
Stephan Mielke, Raquel Nunes, Katayoun Rezvani, et al.
ALTEX
|
April 18, 2020
Inflammation-induced tissue damage mimicking GvHD in human skin models as test-platform for immunotherapeutics
Julia Wallstabe, Lydia Bussemer, Florian Groeber-Becker, et al.
Leukemia
|
February 13, 2020
ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia
Denis Claude Roy, Irwin Walker, Johan Maertens, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 126) with videos related to
Sort By:
Page
of 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2005
T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization
Katayoun Rezvani, Jason M Brenchley, David A Price, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2007
Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation
Bipin N Savani, Stephan Mielke, Katayoun Rezvani, et al.
Blood
|
November 8, 2008
Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
Katayoun Rezvani, Agnes S M Yong, Abdul Tawab, et al.
Blood
|
November 15, 2014
Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy
Mathias Lutz, Andrea Worschech, Miriam Alb, et al.
Haematologica
|
December 8, 2010
Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies
Katayoun Rezvani, Agnes S M Yong, Stephan Mielke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2005
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel
Anja Henningsson, Sharon Marsh, Walter J Loos, et al.
Cancer Immunology, Immunotherapy : CII
|
December 27, 2011
Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy
Katayoun Rezvani, Agnes S M Yong, Stephan Mielke, et al.
Blood
|
September 20, 2007
A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique
Stephan Mielke, Raquel Nunes, Katayoun Rezvani, et al.
ALTEX
|
April 18, 2020
Inflammation-induced tissue damage mimicking GvHD in human skin models as test-platform for immunotherapeutics
Julia Wallstabe, Lydia Bussemer, Florian Groeber-Becker, et al.
Leukemia
|
February 13, 2020
ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia
Denis Claude Roy, Irwin Walker, Johan Maertens, et al.
Page
of 13